Hamza, S.A., Haddad, N.I.A. and Gawwam, G.A. (2026) “The Rate Of Disease Progression In MS Patients Treated With Rituximab And Ocrelizumab: A Comparative Study”, INTERNATIONAL JOURNAL OF ADVANCES IN SIGNAL AND IMAGE SCIENCES, pp. 335–345. doi:10.29284/x4mwhb26.